Liquidia (FRA:LT4) 3-Year EBITDA Growth Rate : 13.20% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Liquidia 3-Year EBITDA Growth Rate?

Liquidia's EBITDA per Share for the three months ended in Mar. 2024 was €-0.46.

During the past 3 years, the average EBITDA Per Share Growth Rate was 13.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 30.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Liquidia was 50.00% per year. The lowest was 2.40% per year. And the median was 13.20% per year.

Competitive Comparison of Liquidia's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Liquidia's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Liquidia's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liquidia's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Liquidia's 3-Year EBITDA Growth Rate falls into.

Liquidia 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Liquidia (FRA:LT4) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Liquidia 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Liquidia's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Liquidia (FRA:LT4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liquidia Corp (FRA:LT4) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

LQDA:USA

Address

419 Davis Drive, Suite 100, Morrisville, NC, USA, 27560

Website

https://www.liquidia.com

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.

Liquidia (FRA:LT4) Headlines

No Headlines